Effect of DPP4 Inhibitors on Cisplatin-induced Acute Kidney Injury
Phase of Trial: Phase II/III
Latest Information Update: 06 Jun 2018
Price : $35 *
At a glance
- Drugs Gemigliptin (Primary) ; Cisplatin
- Indications Acute kidney injury
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 06 Jun 2018 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified April 2016).
- 18 Apr 2016 Planned End Date changed from 1 Oct 2016 to 1 Jun 2018.